|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/68 | |
| C07H 21/04 |
| (11) | Patento numeris | 2439284 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11178194.4 |
| Europos patento paraiškos padavimo data | 2005-03-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-05-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 558218 P | 2004-03-31 | US | |
| 561095 P | 2004-04-09 | US | |
| 565753 P | 2004-04-27 | US | |
| 565985 P | 2004-04-27 | US | |
| 574035 P | 2004-05-25 | US | |
| 577916 P | 2004-06-07 | US | |
| 592287 P | 2004-07-29 | US |
| (72) |
Bell, Daphne Winifred, US
Haber, Daniel A., US
Janne, Pasi Antero, US
Johnson, Bruce E., US
Lynch, Thomas J., US
Meyerson, Matthew, US
Paez, Juan Guillermo, US
Sellers, William R., US
Settleman, Jeffrey E., US
Sordella, Raffaella, US
|
| (73) |
Dana-Farber Cancer Institute, Inc.,
450 Brookline Avenue, Boston, MA 02215,
US
The General Hospital Corporation, 55 Fruit Street, Boston, MA 02114, US |
| (54) | Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |
| Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments |